| Bryan,Garnier & Co | Sébastien Malafosse | +33 (0)1 56 68 75 73 | |
| Invest Securities | Daniel Anizon | +33 (0)1 44 88 77 88 | |
| Société Générale | Rodolphe Besserve | +33 (0)1 42 13 87 43 |
The opinions, assessments or forecasts from these analysts on Innate Pharma performance levels and activities are not necessarily representative of Innate Pharma's ownforecasts, nor are they necessarily shared by its management.